Back
Supernus Pharmaceuticals Vs. United Therapeutics Industry Stock Comparison
Sell
47
SUPN
Supernus Pharmaceuticals
Last Price:
34.66
Seasonality Move:
8.24%
Buy
59
UTHR
United Therapeutics
Last Price:
376.96
Seasonality Move:
11.55%
Sell
47
Supernus Pharmaceuticals (SUPN)
is a Sell
Is Supernus Pharmaceuticals a Buy, Sell or Hold?
- The current Supernus Pharmaceuticals [SUPN] share price is $34.76. The Score for SUPN is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
- SUPN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
59
United Therapeutics (UTHR)
is a Buy
Is United Therapeutics a Buy, Sell or Hold?
- The current United Therapeutics [UTHR] share price is $376.80. The Score for UTHR is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
- UTHR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
SUPN Stock Price Chart
What is Supernus Pharmaceuticals's stock price today?
-
The Supernus Pharmaceuticals share price today is $34.76
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SUPN is experiencing buying pressure, which is a positive indicator for future bullish movement.
UTHR Stock Price Chart
What is United Therapeutics's stock price today?
-
The United Therapeutics share price today is $376.80
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and UTHR is experiencing slight buying pressure.
SUPN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.57 | Buy |
| Relative Strength Index (14 RSI): | 62.37 | Buy |
| Chaikin Money Flow: | 220636 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (32.23 - 34.29) | Buy |
| Bollinger Bands (100): | (28.28 - 34.08) | Buy |
UTHR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.26 | Buy |
| Relative Strength Index (14 RSI): | 65.01 | Buy |
| Chaikin Money Flow: | 108847 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (350.76 - 367.98) | Buy |
| Bollinger Bands (100): | (319.39 - 359.07) | Buy |
SUPN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 34.25 | Buy |
| 20-day SMA: | 33.6 | Buy |
| 50-day SMA: | 33.04 | Buy |
| 200-day SMA: | 30.53 | Buy |
| 8-day EMA: | 34.24 | Buy |
| 20-day EMA: | 33.68 | Buy |
| 50-day EMA: | 32.84 | Buy |
| 200-day EMA: | 31.03 | Buy |
UTHR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 360.88 | Buy |
| 20-day SMA: | 360.5 | Buy |
| 50-day SMA: | 355.15 | Buy |
| 200-day SMA: | 289.97 | Buy |
| 8-day EMA: | 366.26 | Buy |
| 20-day EMA: | 361.3 | Buy |
| 50-day EMA: | 352.78 | Buy |
| 200-day EMA: | 305.88 | Buy |
Supernus Pharmaceuticals Earnings Growth & SUPN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.02 per share, and a decrease next year of $0.18 per share.
United Therapeutics Earnings Growth & UTHR Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $6.10 per share, and an increase next year of $2.37 per share.
Supernus Pharmaceuticals Technical Analysis
| Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
United Therapeutics Technical Analysis
| Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||